Pieces of a new state law regulating third-party health care companies are likely to remain on hold — but only for certain companies — a federal judge appeared to indicate.

As one FDA initiative works to sustain the momentum of rare disease research, other events threaten to slow progress.

The FDA has accepted the New Drug Application for doravirine/islatravir for adults with virologically-suppressed HIV-1 infection.

Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees ...

According to Makary, reducing user fees—which make up just under half of the FDA's budget—could make it easier for smaller ...